Rare cancers are less known and pose challenges due to limited research and diagnostic difficulties. Environmental factors, ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

AI can summarize doctor-patient interactions, helping physicians produce visit notes for records and follow-up care. LLMs can even do this in the doctor’s voice. It’s not flawless, though.

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

ITM announces positive Phase 3 results for ITM-11 in neuroendocrine tumours, paving the way for a potential new treatment ...

Gigi Moore’s tumor is caused by Zollinger-Ellison Syndrome, a rare cancer mostly found in men over 50. Since her diagnosis, James has been right by her side.

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

Exelixis, Inc. (NASDAQ:EXEL), a biopharmaceutical company with a market capitalization of $9.4 billion focused on developing and commercializing novel therapies for cancer treatment, stands at a ...

The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce Professor Ashley Grossman, F.Med.Sci., as the winner of the 2025 Transatlantic Alliance Award.

MAHTAB SOHREVARDI ENDOCRINOLOGY Physician Huntington Health Dr. Mahtab Sohrevardi’s area of interest is thyroidal disorders ...